2023 Inova Fairfax Medicine Grand Rounds (Enduring Material) 10.31.2023

Topic: Antibody Drug Conjugates: A Breakthrough in Breast Cancer Treatment

Learning Objectives

  • Advance education in basic scientific principles applicable to clinical situations.
  • Disseminate information regarding disease prevention and public health.
  • Improve understanding of psychosocial and legal issues as they apply to delivery of excellent patient care.
  • Provide updates in medical diagnosis and treatment to improve patient outcome.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
10/31/2023
Course expires: 
10/30/2024
Cost:
$0.00
Part of: 
2023 Inova Fairfax Medicine Grand Rounds (Enduring Material)
Rating: 
0
Speaker(s)

Kathleen Harnden, MD MBA

has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Astrazeneca;.
has a financial relationship (Professional Services) with Daiichi Sankyo;.
has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Professional Services) with SeaGen;.

Accreditation Statement

The Inova Office of Continuing Medical Education is accredited by the Medical Society of Virginia to provide continuing medical education for physicians.

Credit Designation Statement

The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 1.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency an

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.